Moisand Fitzgerald Tamayo LLC Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Moisand Fitzgerald Tamayo LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 224 shares of the healthcare conglomerate’s stock after selling 29 shares during the period. Moisand Fitzgerald Tamayo LLC’s holdings in UnitedHealth Group were worth $131,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Bornite Capital Management LP bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $15,794,000. Bell Investment Advisors Inc grew its stake in shares of UnitedHealth Group by 4.8% during the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after buying an additional 24 shares during the last quarter. Baird Financial Group Inc. grew its stake in shares of UnitedHealth Group by 71.0% during the fourth quarter. Baird Financial Group Inc. now owns 476,586 shares of the healthcare conglomerate’s stock valued at $250,909,000 after buying an additional 197,834 shares during the last quarter. Bradley Foster & Sargent Inc. CT grew its stake in shares of UnitedHealth Group by 7.3% during the fourth quarter. Bradley Foster & Sargent Inc. CT now owns 149,535 shares of the healthcare conglomerate’s stock valued at $78,726,000 after buying an additional 10,212 shares during the last quarter. Finally, Harbert Fund Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter worth approximately $1,316,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Trading Up 1.1 %

UNH opened at $597.68 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The stock has a market capitalization of $551.91 billion, a PE ratio of 39.63, a P/E/G ratio of 1.65 and a beta of 0.58. The business’s 50 day moving average price is $583.48 and its 200 day moving average price is $530.04. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the prior year, the firm posted $6.14 earnings per share. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 55.70%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Truist Financial increased their target price on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Royal Bank of Canada increased their target price on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Wells Fargo & Company increased their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. HSBC increased their target price on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 1st. Two research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $617.37.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.